You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, T-Cell, Cutaneous

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cutaneous T Cell Lymphoma Trial in Pittsburgh (Micro needle array-Doxorubicin (MNA-D))

Recruiting
  • Cutaneous T Cell Lymphoma
  • Micro needle array-Doxorubicin (MNA-D)
  • Pittsburgh, Pennsylvania
    University Of Pittsburgh Medical Center
Jun 2, 2022

Peripheral T Cell Lymphoma (PTCL), Cell Therapy Trial in United States (MT-101, MT-101 + Conditioning (Lymphodepleting)

Recruiting
  • Lymphoma, T-Cell, Peripheral
  • +4 more
  • MT-101
  • MT-101 + Conditioning (Lymphodepleting) Chemotherapy
  • Duarte, California
  • +8 more
Jan 27, 2023

Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma

Not yet recruiting
  • Cutaneous T Cell Lymphoma
  • +2 more
    • Ancona, Italy
    • +19 more
    Nov 2, 2023

    Recurrent Adult T-Cell Leukemia/Lymphoma, Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Adult T-Cell

    Recruiting
    • Recurrent Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Nov 18, 2022

    Quality of Life in Cutaneous Lymphoma Patients Using Skindex29

    Not yet recruiting
    • Cutaneous Lymphoma
    • Quality-of-Life Assessment
    • Questionnaire Administration
    • Duarte, California
      City of Hope Medical Center
    Aug 23, 2022

    Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB) Trial in Bordeaux, Paris (chlormethine gel)

    Recruiting
    • Early Stage Mycosis Fungoides Cutaneous T Cell Lymphoma (MF-CTCL) (Stage IA-IB)
    • chlormethine gel
    • Bordeaux, France
    • +1 more
    Aug 17, 2022

    Advanced Solid Tumor, Cutaneous T Cell Lymphoma Trial in Guanzhou (SIM1811-03)

    Recruiting
    • Advanced Solid Tumor
    • Cutaneous T Cell Lymphoma
    • Guanzhou, Guangdong, China
      Sun Yat-Sen University Cancer Center
    Mar 10, 2023

    Diagnostic Classifier for Cutaneous T-cell Lymphomas

    Recruiting
    • CTCL/ Mycosis Fungoides
    • Skin suction blistering and skin biopsies
    • Vienna, Austria
      Medical University of Vienna
    Apr 4, 2022

    Cutaneous T-cell Lymphoma Trial in New York (Bexarotene, Total Skin Electron Beam (TSEB))

    Recruiting
    • Cutaneous T-cell Lymphoma
    • New York, New York
      Memorial Sloan Kettering Cancer Center (All Protocol Activities)
    Sep 19, 2022

    T-cell Lymphoma, NK-Cell Lymphoma, T-cell Prolymphocytic Leukemia Trial in United States (Optional Blood Sample, Optional Nail

    Recruiting
    • T-cell Lymphoma
    • +30 more
    • Optional Blood Sample
    • Optional Nail Sample
    • Duarte, California
    • +25 more
    Jul 28, 2023

    Folliculotropic Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Duarte (procedure,

    Active, not recruiting
    • Folliculotropic Mycosis Fungoides
    • +7 more
    • Extracorporeal Photopheresis
    • +3 more
    • Duarte, California
      City of Hope Medical Center
    Dec 8, 2022

    Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous

    Active, not recruiting
    • Epidermotropic T-cell Lymphomas
    • HSCT
    • Standard Care
    • Paris, France
      Saint Louis hospital
    Apr 15, 2022

    Hairy Cell and Other Leukemias, and to Develop Recombinant

    Recruiting
    • Hairy Cell Leukemia (HCL)
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Large B-Cell, Diffuse Trial in Spain (Registry of

      Recruiting
      • Lymphoma, T-Cell, Cutaneous
      • +5 more
      • Registry of patients (exposure is Cutaneous Lymphoma)
      • Barcelona, Spain
      • +13 more
      Mar 15, 2022

      Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)

      Active, not recruiting
      • Advanced Cancer
      • +16 more
      • Scottsdale, Arizona
      • +3 more
      Dec 22, 2022

      Pediatric Cancer, Hodgkin Disease, CD30-Positive DLBCL Trial in Milwaukee (anti-CD30 Bispecific Antibody-armed

      Not yet recruiting
      • Pediatric Cancer
      • +11 more
      • anti-CD30 Bispecific Antibody-armed anti-CD3-Activated Autologous T-cells (CD30 biAb-AATC)
      • Milwaukee, Wisconsin
        Children's Wisconsin
      Sep 14, 2022

      Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection Trial in Besançon (Samples collection)

      Recruiting
      • Cutaneous T-Cell Lymphoma
      • +2 more
      • Samples collection
      • Besançon, France
        Centre Hospitalier Universitaire de Besançon
      May 31, 2022

      Characterization of the Microbiome in Cutaneous T Cell Lymphoma

      Recruiting
      • Cutaneous T Cell Lymphoma
        • Chicago, Illinois
          Northwestern University
        Oct 2, 2021

        T-Cell Lymphoma, Peripheral T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma Refractory Trial in United States (LB1901)

        Active, not recruiting
        • T-Cell Lymphoma
        • +4 more
        • LB1901
        • Rochester, Minnesota
        • +3 more
        Feb 15, 2022

        Mantle Cell Lymphoma, Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Augusta, Nashville, Houston

        Recruiting
        • Mantle Cell Lymphoma
        • +9 more
        • L-Bcl-2 antisense oligonucleotide
        • Augusta, Georgia
        • +2 more
        Nov 18, 2022

        Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

        Recruiting
        • Non Hodgkin Lymphoma (NHL)
        • +4 more
        • Orange, California
        • +8 more
        Nov 29, 2022

        Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford, Chicago, Houston (Sapacitabine)

        Terminated
        • Cutaneous T-cell Lymphoma (CTCL)
        • Stanford, California
        • +2 more
        Dec 7, 2021

        B-Cell Prolymphocytic Leukemia, Chronic Lymphocytic Leukemia, Peripheral T-Cell Lymphoma Trial in Columbus (Letermovir)

        Recruiting
        • B-Cell Prolymphocytic Leukemia
        • +5 more
        • Columbus, Ohio
          Ohio State University Comprehensive Cancer Center
        Nov 18, 2022

        Cutaneous T-cell Lymphoma (CTCL) Trial in United Kingdom (CDK-003)

        Recruiting
        • Cutaneous T-cell Lymphoma (CTCL)
        • CDK-003
        • Birmingham, United Kingdom
        • +3 more
        Apr 22, 2022

        Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Angioimmunoblastic T-Cell Lymphoma, Recurrent Grade 1

        Active, not recruiting
        • Advanced Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
        • +18 more
        • Anti-ICOS Monoclonal Antibody MEDI-570
        • +2 more
        • Duarte, California
        • +22 more
        Jan 18, 2023